| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 578 | 2008 |
| High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse C Piketty, TM Darragh, MD Costa, P Bruneval, I Heard, MD Kazatchkine, ... Annals of internal medicine 138 (6), 453-459, 2003 | 388 | 2003 |
| Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy C Piketty, H Selinger-Leneman, S Grabar, C Duvivier, M Bonmarchand, ... Aids 22 (10), 1203-1211, 2008 | 342 | 2008 |
| Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease C Piketty, P Castiel, L Belec, D Batisse, AS Mohamed, J Gilquin, ... Aids 12 (7), 745-750, 1998 | 262 | 1998 |
| High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results … Y Yazdanpanah, C Fagard, D Descamps, AM Taburet, C Colin, ... Clinical Infectious Diseases 49 (9), 1441-1449, 2009 | 261 | 2009 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 259 | 2008 |
| Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients AM Taburet, C Piketty, C Chazallon, I Vincent, L Gérard, V Calvez, ... Antimicrobial agents and chemotherapy 48 (6), 2091-2096, 2004 | 243 | 2004 |
| Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus JI Silverberg, A Pinter, G Pulka, Y Poulin, JD Bouaziz, A Wollenberg, ... Journal of Allergy and Clinical Immunology 145 (1), 173-182, 2020 | 240 | 2020 |
| Anti‐hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV‐infected patients Y Benhamou, H Fleury, P Trimoulet, I Pellegrin, R Urbinelli, C Katlama, ... Hepatology 43 (3), 548-555, 2006 | 223 | 2006 |
| Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV C Piketty, H Selinger-Leneman, AM Bouvier, A Belot, M Mary-Krause, ... Journal of clinical oncology 30 (35), 4360-4366, 2012 | 210 | 2012 |
| High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy C Piketty, TM Darragh, I Heard, M Da Costa, P Bruneval, MD Kazatchkine, ... Sexually transmitted diseases 31 (2), 96-99, 2004 | 199 | 2004 |
| Acquired resistance to echinocandins in Candida albicans: case report and review MT Baixench, N Aoun, M Desnos-Ollivier, D Garcia-Hermoso, S Bretagne, ... Journal of antimicrobial chemotherapy 59 (6), 1076-1083, 2007 | 198 | 2007 |
| Long-term clinical outcome of human immunodeficiency virus–infected patients with discordant immunologic and virologic responses to a protease inhibitor–containing regimen C Piketty, L Weiss, F Thomas, AS Mohamed, L Belec, MD Kazatchkine The Journal of infectious diseases 183 (9), 1328-1335, 2001 | 193 | 2001 |
| Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy J Serpaggi, ML Chaix, D Batisse, C Dupont, A Vallet-Pichard, H Fontaine, ... Aids 20 (2), 233-240, 2006 | 173 | 2006 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 167 | 2008 |
| Renal lesions in HIV-1-positive patient treated with tenofovir C Créput, G Gonzalez-Canali, G Hill, C Piketty, M Kazatchkine, D Nochy Aids 17 (6), 935-937, 2003 | 154 | 2003 |
| Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus–infected men: results from the FHDH-ANRS CO4 cohort W Jarzebowski, E Caumes, N Dupin, D Farhi, AS Lascaux, C Piketty, ... Archives of internal medicine 172 (16), 1237-1243, 2012 | 132 | 2012 |
| Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to … C Piketty, E Race, P Castiel, L Belec, G Peytavin, A Si-Mohamed, ... Aids 13 (11), F71-F77, 1999 | 132 | 1999 |
| Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients A Landau, D Batisse, JPD Van Huyen, C Piketty, F Bloch, G Pialoux, ... Aids 14 (7), 839-844, 2000 | 129 | 2000 |
| Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients A Landau, D Batisse, C Piketty, JPD Van Huyen, F Bloch, L Belec, ... Aids 15 (16), 2149-2155, 2001 | 118 | 2001 |
